NCT03749031

Brief Summary

This is a randomized crossover intervention designed to evaluate effects of daily intake of beverages containing orange or apple Pomace on gastrointestinal function as measured by stool frequency. Additional outcomes will include aspects of digestive health and self-reported GI symptoms and dietary intake as well as analysis of gut microbiota.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 19, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 21, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2019

Completed
Last Updated

December 20, 2019

Status Verified

December 1, 2019

Enrollment Period

11 months

First QC Date

November 19, 2018

Last Update Submit

December 17, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • stool frequency

    Bowel habits daily diary as weekly averages. Fewer days with no stool, and higher number of stools per week would be better.

    Changes over 7 weeks (daily during 4 week treatment followed by daily during 3 week washout) compared to baseline (daily during 2 week run-in)

Secondary Outcomes (5)

  • Self-reported GI symptoms

    Changes over 7 weeks (daily during 4 week treatment followed by daily during 3 week washout) compared to baseline (daily during 2 week run-in)

  • Stool consistency

    Changes over 7 weeks (daily during 4 week treatment followed by daily during 3 week washout) compared to baseline (daily during 2 week run-in)

  • Ease of stool passage

    Changes over 7 weeks (daily during 4 week treatment followed by daily during 3 week washout) compared to baseline (daily during 2 week run-in)

  • microbiota changes

    Changes from baseline sample to end of treatment sample (Week 4) and end of 3 week washout sample (Week 7)

  • Dietary analysis

    Changes from 2 week run in (baseline) to the last week of treatment (Week 4) and the last week of 3 week washout (Week 7)

Study Arms (4)

Orange juice only

PLACEBO COMPARATOR

16 oz. orange juice per day for 4 weeks

Other: Orange Juice

orange juice + orange Pomace

EXPERIMENTAL

16 oz. orange juice + orange Pomace per day for 4 weeks

Other: Orange juice + Orange Pomace

Apple juice only

PLACEBO COMPARATOR

16 oz. apple juice per day for 4 weeks

Other: Apple Juice

Apple Juice + Apple Pomace

EXPERIMENTAL

16 oz. apple juice + apple Pomace per day for 4 weeks

Other: Apple Juice and Apple Pomace

Interventions

16 oz. orange juice + orange Pomace per day for 4 weeks

orange juice + orange Pomace

16 oz. orange juice per day for 4 weeks

Orange juice only

16 oz. apple juice and apple Pomace per day for 4 weeks

Apple Juice + Apple Pomace

16 oz. apple juice per day for 4 weeks

Apple juice only

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy males and females 18-60 years old
  • Willing and able to consume 16 oz. of orange or apple beverage per day for 4 week periods
  • Willing to maintain usual diet, smoking status, physical activity pattern, supplements and meds

You may not qualify if:

  • Food allergies or sensitivities to ingredients in study beverages
  • Presence or history of GI condition, endocrine (including diabetes), cardiovascular disease or other disease or condition that could interfere in the interpretation of the study results in the opinion of the Investigator.
  • Extreme dietary habits including vegetarian, vegan or Atkins diet
  • Females or are pregnant, planning to become pregnant or breast feeding during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BioFortis

Addison, Illinois, 60101, United States

Location

Study Officials

  • Kathleen Kelley, MD

    BioFortis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2018

First Posted

November 21, 2018

Study Start

October 15, 2018

Primary Completion

August 30, 2019

Study Completion

August 30, 2019

Last Updated

December 20, 2019

Record last verified: 2019-12

Locations